With Fewer Resources, Clinical Trials Need Interoperability More Than Ever
The following is a guest article by Jiang Li, CEO at Vivalink
Decentralized and hybrid clinical trials gained traction out of necessity. During the pandemic, many teams had to shift quickly to telehealth, remote monitoring,…

